urea has been researched along with Psoriasis in 61 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " To compare the efficacy and safety of intralesional injection of 5-fluorouracil (5-FU), methotrexate (MTX), triamcinolone acetonide (TA) versus topical calcipotriol plus urea 20% in the treatment of nail psoriasis." | 9.51 | Topical calcipotriol combined with urea 20% versus intralesional injection of triamcinolone acetonide, 5-fluorouracil, and methotrexate in the treatment of nail psoriasis: A comparative study. ( Abdelmeniem, IM; El Eryan, IM; Fouda, I; Nofal, A; Omar, SS, 2022) |
| "The mechanisms of action of urea-containing ointments in the treatment of eczema, ichthyosis and psoriasis are only partly known and related to proteolysis and keratinolysis." | 9.08 | Topical treatment by urea reduces epidermal hyperproliferation and induces differentiation in psoriasis. ( Hagemann, I; Proksch, E, 1996) |
| "Dithranol (anthralin) is one of the basic compounds used in the treatment of psoriasis vulgaris." | 8.77 | [Urea in combination with dithranol in treating psoriasis vulgaris]. ( Bieber, K; Kaudewitz, P; Przybilla, B, 1989) |
| "We carried out an observational study to evaluate the efficacy, skin acceptability and cosmetic qualities of a cream formulation, based on 40% urea and amino-inositol, in the treatment of mild psoriasis in the absence of other associated cosmetic/pharmacological treatments." | 8.12 | Assessment of the efficacy, skin acceptability and cosmetic quality of an adjuvant cream based on 40% urea and amino-inositol in the treatment of mild psoriasis. ( Fabbrocini, G; Genco, L; Megna, M; Noto, M; Potestio, L, 2022) |
| "We performed a prospective observational study with an emollient containing 10% urea, ceramides, glycerin and glyceryl glucoside in patients suffering from mild to moderate psoriasis." | 8.02 | [Influence of an adjuvant treatment with an emollient containing 10 % urea, ceramides, glycerin und glyceryl glucoside in patients with psoriasis vulgaris]. ( Nippel, G; Presto, S; Sammain, A; Schmidt, L; Schölermann, A; Tsianakas, A; von Martial, S, 2021) |
| "In an open multicentre drug monitoring survey, 1611 patients with atopic dermatitis, contact eczema, dry eczema, psoriasis and pruritus were treated with a preparation containing 5% urea and 3% polidocanol (laurylmacrogol)." | 7.69 | Results of a postmarketing drug monitoring survey with a polidocanol-urea preparation for dry, itching skin. ( Freitag, G; Höppner, T, 1997) |
| "In the treatment of psoriasis with urea and urea-combined preparations, the individual sequence should be so clearly prescribed such that acceptance is assured." | 7.67 | [Urea and urea combinations in psoriasis]. ( Rohde, BT, 1989) |
| "The topical treatment of active chronic psoriasis can be achieved as effectively with 0,1% dithranol + 17% urea as with triamcinolone acetonite 0,1%." | 7.66 | [Dithranol-urea treatment of chronic psoriasis. A comparison of 0,1% dithranol + 17% urea with triamcinolone acetonite 0,1% and phototherapy (author's transl)]. ( Ernst, TM, 1981) |
| " To compare the efficacy and safety of intralesional injection of 5-fluorouracil (5-FU), methotrexate (MTX), triamcinolone acetonide (TA) versus topical calcipotriol plus urea 20% in the treatment of nail psoriasis." | 5.51 | Topical calcipotriol combined with urea 20% versus intralesional injection of triamcinolone acetonide, 5-fluorouracil, and methotrexate in the treatment of nail psoriasis: A comparative study. ( Abdelmeniem, IM; El Eryan, IM; Fouda, I; Nofal, A; Omar, SS, 2022) |
| "Psoriasis is a chronic T-cell-mediated autoimmune disease, and FMS-like tyrosine kinase 3 (FLT3) has been considered as a potential molecular target for the treatment of psoriasis." | 5.43 | Drug Discovery against Psoriasis: Identification of a New Potent FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor, 1-(4-((1H-Pyrazolo[3,4-d]pyrimidin-4-yl)oxy)-3-fluorophenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea, That Showed Potent Activity in a Psoriatic Anim ( Chen, YC; Fang, Z; Huang, SZ; Ji, S; Li, GB; Li, LL; Ma, S; Niu, D; Wang, JH; Wang, LJ; Xiang, R; Xiong, Y; Yang, LL; Yang, SY; Zhang, G; Zhong, JM, 2016) |
| "The mechanisms of action of urea-containing ointments in the treatment of eczema, ichthyosis and psoriasis are only partly known and related to proteolysis and keratinolysis." | 5.08 | Topical treatment by urea reduces epidermal hyperproliferation and induces differentiation in psoriasis. ( Hagemann, I; Proksch, E, 1996) |
| "Topical vehicles containing urea are increasingly used in dermatology because of their favorable pharmacological properties, which are due to the following capacities of urea: (1) its beneficial influence on the structure and physiology of the skin, and (2) its therapeutic effect in combination with other topically active agents in various skin diseases, such as psoriasis, ichthyosis, and chronic eczema." | 4.78 | [Clinical experiences of interval treatment with dermatologic agents containing urea]. ( Antal, I; Füzesi, S; Petres, J, 1990) |
| "Dithranol (anthralin) is one of the basic compounds used in the treatment of psoriasis vulgaris." | 4.77 | [Urea in combination with dithranol in treating psoriasis vulgaris]. ( Bieber, K; Kaudewitz, P; Przybilla, B, 1989) |
| "We carried out an observational study to evaluate the efficacy, skin acceptability and cosmetic qualities of a cream formulation, based on 40% urea and amino-inositol, in the treatment of mild psoriasis in the absence of other associated cosmetic/pharmacological treatments." | 4.12 | Assessment of the efficacy, skin acceptability and cosmetic quality of an adjuvant cream based on 40% urea and amino-inositol in the treatment of mild psoriasis. ( Fabbrocini, G; Genco, L; Megna, M; Noto, M; Potestio, L, 2022) |
| "We performed a prospective observational study with an emollient containing 10% urea, ceramides, glycerin and glyceryl glucoside in patients suffering from mild to moderate psoriasis." | 4.02 | [Influence of an adjuvant treatment with an emollient containing 10 % urea, ceramides, glycerin und glyceryl glucoside in patients with psoriasis vulgaris]. ( Nippel, G; Presto, S; Sammain, A; Schmidt, L; Schölermann, A; Tsianakas, A; von Martial, S, 2021) |
| "In an open multicentre drug monitoring survey, 1611 patients with atopic dermatitis, contact eczema, dry eczema, psoriasis and pruritus were treated with a preparation containing 5% urea and 3% polidocanol (laurylmacrogol)." | 3.69 | Results of a postmarketing drug monitoring survey with a polidocanol-urea preparation for dry, itching skin. ( Freitag, G; Höppner, T, 1997) |
| "Preparations containing urea were found to be effective in the treatment of ichthyosis vulgaris and so we were encouraged to test their use in other dry skin conditions." | 3.67 | [Urea as a single drug in dry skin]. ( Swanbeck, G, 1989) |
| "In the treatment of psoriasis with urea and urea-combined preparations, the individual sequence should be so clearly prescribed such that acceptance is assured." | 3.67 | [Urea and urea combinations in psoriasis]. ( Rohde, BT, 1989) |
| "The topical treatment of active chronic psoriasis can be achieved as effectively with 0,1% dithranol + 17% urea as with triamcinolone acetonite 0,1%." | 3.66 | [Dithranol-urea treatment of chronic psoriasis. A comparison of 0,1% dithranol + 17% urea with triamcinolone acetonite 0,1% and phototherapy (author's transl)]. ( Ernst, TM, 1981) |
| "Urea is a major component of many daily skincare products which is widely used." | 1.56 | Mode of action of urea. ( Dirschka, T, 2020) |
| "Psoriasis is a chronic T-cell-mediated autoimmune disease, and FMS-like tyrosine kinase 3 (FLT3) has been considered as a potential molecular target for the treatment of psoriasis." | 1.43 | Drug Discovery against Psoriasis: Identification of a New Potent FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor, 1-(4-((1H-Pyrazolo[3,4-d]pyrimidin-4-yl)oxy)-3-fluorophenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea, That Showed Potent Activity in a Psoriatic Anim ( Chen, YC; Fang, Z; Huang, SZ; Ji, S; Li, GB; Li, LL; Ma, S; Niu, D; Wang, JH; Wang, LJ; Xiang, R; Xiong, Y; Yang, LL; Yang, SY; Zhang, G; Zhong, JM, 2016) |
| "Salicylic acid ointment was applied on one and carbamide ointment on the other back of the hand." | 1.28 | [Water content of the skin following salicylic acid and urea treatment]. ( Jakab, E; Rácz, I; Soós, G, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 40 (65.57) | 18.7374 |
| 1990's | 6 (9.84) | 18.2507 |
| 2000's | 3 (4.92) | 29.6817 |
| 2010's | 8 (13.11) | 24.3611 |
| 2020's | 4 (6.56) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelmeniem, IM | 1 |
| El Eryan, IM | 1 |
| Nofal, A | 1 |
| Fouda, I | 1 |
| Omar, SS | 1 |
| Megna, M | 1 |
| Potestio, L | 1 |
| Genco, L | 1 |
| Noto, M | 1 |
| Fabbrocini, G | 1 |
| Dirschka, T | 1 |
| von Martial, S | 1 |
| Nippel, G | 1 |
| Schmidt, L | 1 |
| Sammain, A | 1 |
| Schölermann, A | 1 |
| Presto, S | 1 |
| Tsianakas, A | 1 |
| Ottas, A | 1 |
| Fishman, D | 1 |
| Okas, TL | 1 |
| Kingo, K | 1 |
| Soomets, U | 1 |
| Price, L | 1 |
| Lesesky, E | 1 |
| Hussain, H | 1 |
| Ziegler, J | 1 |
| Hause, G | 1 |
| Wohlrab, J | 1 |
| Neubert, RHH | 1 |
| Micali, G | 1 |
| Verzì, AE | 1 |
| Musumeci, ML | 1 |
| Luca, M | 1 |
| Lacarrubba, F | 1 |
| Thaçi, D | 1 |
| Augustin, M | 2 |
| Krutmann, J | 1 |
| Luger, T | 1 |
| Li, GB | 1 |
| Ma, S | 1 |
| Yang, LL | 1 |
| Ji, S | 1 |
| Fang, Z | 1 |
| Zhang, G | 1 |
| Wang, LJ | 1 |
| Zhong, JM | 1 |
| Xiong, Y | 1 |
| Wang, JH | 1 |
| Huang, SZ | 1 |
| Li, LL | 1 |
| Xiang, R | 1 |
| Niu, D | 1 |
| Chen, YC | 1 |
| Yang, SY | 1 |
| Jäger, K | 1 |
| Garreis, F | 1 |
| Posa, A | 1 |
| Dunse, M | 1 |
| Paulsen, FP | 1 |
| Sticherling, M | 1 |
| Boehncke, WH | 1 |
| Christophers, E | 1 |
| Domm, S | 1 |
| Gollnick, H | 1 |
| Reich, K | 1 |
| Mrowietz, U | 1 |
| KABELITZ, G | 1 |
| KAPPEL, W | 1 |
| ACHENBACH, R | 1 |
| HEITE, HJ | 1 |
| MULLER, SA | 1 |
| KIERLAND, RR | 1 |
| Grills, C | 1 |
| Burge, S | 1 |
| Periti, I | 1 |
| Zendri, E | 1 |
| Ficarelli, E | 1 |
| Masotti, A | 1 |
| De Panfilis, G | 1 |
| Portnoy, B | 1 |
| Beck, MH | 1 |
| Guerrier, CJ | 1 |
| Porter, DI | 1 |
| Peachey, RD | 1 |
| Burton, JL | 1 |
| Khan, SA | 1 |
| Williamson, DM | 1 |
| Gatecliff, M | 1 |
| Tosh, J | 1 |
| Young, MM | 1 |
| Konopík, J | 2 |
| Krs, V | 2 |
| Záruba, F | 2 |
| Taube, KM | 2 |
| Zaumseil, RP | 1 |
| Wohlrab, W | 2 |
| Reiss, CJ | 1 |
| Ernst, TM | 2 |
| Rubin, J | 1 |
| Rust, P | 1 |
| Brown, P | 1 |
| Popovich, RP | 1 |
| Nolph, KD | 1 |
| South, DA | 1 |
| Farber, EM | 3 |
| Schöpf, E | 1 |
| Mueller, JM | 1 |
| Ostermann, T | 1 |
| Proksch, E | 2 |
| Hagemann, I | 1 |
| Freitag, G | 1 |
| Höppner, T | 1 |
| Höxtermann, S | 1 |
| Nüchel, C | 1 |
| Altmeyer, P | 1 |
| Shemer, A | 1 |
| Nathansohn, N | 1 |
| Kaplan, B | 1 |
| Weiss, G | 1 |
| Newman, N | 1 |
| Trau, H | 1 |
| Buckley, DB | 1 |
| Thaler, MP | 1 |
| Fukuyama, K | 1 |
| Inoue, N | 1 |
| Cram, DL | 1 |
| Epstein, WL | 1 |
| Blair, C | 1 |
| Petres, J | 1 |
| Antal, I | 1 |
| Füzesi, S | 1 |
| Przybilla, B | 2 |
| Kaudewitz, P | 2 |
| Bieber, K | 1 |
| Swanbeck, G | 2 |
| Rácz, I | 1 |
| Soós, G | 1 |
| Jakab, E | 1 |
| Rohde, BT | 1 |
| Döring, HF | 1 |
| Ferrando, J | 1 |
| Fiedler, H | 1 |
| Wozniak, KD | 1 |
| Beare, JM | 1 |
| Weber, G | 1 |
| Stetter, H | 1 |
| Peck, GL | 1 |
| Guss, SB | 1 |
| Key, DJ | 1 |
| Warren, DJ | 1 |
| Winney, RJ | 1 |
| Beveridge, GW | 1 |
| Zackheim, HS | 2 |
| Solente, G | 1 |
| Shuster, S | 1 |
| Johnson, C | 1 |
| Slavík, M | 1 |
| Elis, J | 1 |
| Belsan, I | 2 |
| Lichá, K | 1 |
| Fry, L | 1 |
| Macdonald, A | 1 |
| McMinn, RM | 1 |
| Seutter, E | 1 |
| Goedhart-de Groot, N | 1 |
| Sutorius, AH | 1 |
| Urselmann, EJ | 1 |
| Kloss, G | 1 |
| Schwarz, E | 1 |
| Krs, C | 1 |
| Zvĕreva, E | 1 |
| Spanlangová, I | 1 |
7 reviews available for urea and Psoriasis
| Article | Year |
|---|---|
Importance of basic therapy in psoriasis.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Ceramides; Dermatologic Agents; Evidence-Based | 2015 |
Functional relationship between cationic amino acid transporters and beta-defensins: implications for dry skin diseases and the dry eye.
Topics: Amino Acid Transport Systems, Basic; Arginine; beta-Defensins; Biological Transport; Child, Preschoo | 2010 |
[Value of adjuvant basic therapy in chronic recurrent skin diseases. Neurodermatitis atopica/psoriasis vulgaris].
Topics: Adrenal Cortex Hormones; Baths; Combined Modality Therapy; Cost-Benefit Analysis; Dermatitis, Atopic | 1995 |
[Urea in dermatology].
Topics: Eczema; Humans; Psoriasis; Skin Diseases; Urea | 1994 |
[Clinical experiences of interval treatment with dermatologic agents containing urea].
Topics: Dermatologic Agents; Eczema; Humans; Neurodermatitis; Pharmaceutical Vehicles; Psoriasis; Skin; Urea | 1990 |
[Urea in combination with dithranol in treating psoriasis vulgaris].
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Drug Therapy, Combination; Glucocortic | 1989 |
Advances in the treatment of diseases of the skin.
Topics: Acne Vulgaris; Alopecia Areata; Dermatitis, Contact; Humans; Lupus Erythematosus, Systemic; Lymphati | 1971 |
14 trials available for urea and Psoriasis
| Article | Year |
|---|---|
Topical calcipotriol combined with urea 20% versus intralesional injection of triamcinolone acetonide, 5-fluorouracil, and methotrexate in the treatment of nail psoriasis: A comparative study.
Topics: Calcitriol; Dermatologic Agents; Fluorouracil; Humans; Injections, Intralesional; Methotrexate; Nail | 2022 |
The treatment of active chronic psoriasis: a comparison of the effectiveness of a preparation containing 0.1% dithranol and 17% urea in a cream base and 0.1% dithranol in Lassar's past B.P.C.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Chronic Disease; Clinical Trials as Topic; Female; | 1981 |
An open assessment of 0.1% dithranol in a 17% urea base ('Psoradrate' 0.1%) in the treatment of psoriasis of children.
Topics: Administration, Topical; Adolescent; Anthracenes; Anthralin; Child; Child, Preschool; Clinical Trial | 1983 |
A double-blind comparison of 0.1% dithranol and 17% urea (Psoradrate cream) and 0.25%-dithranol in vanishing cream (Dithrocream) in the treatment of psoriasis.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Clinical Trials as Topic; Double-Blind Method; Fema | 1982 |
The treatment of chronic psoriasis a two-centre comparative study.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Chronic Disease; Clinical Trials as Topic; Coal Tar | 1981 |
Treatment of chronic plaque psoriasis with dithranol and urea creams: a double-blind study.
Topics: Administration, Topical; Adult; Aged; Anthracenes; Anthralin; Clinical Trials as Topic; Double-Blind | 1982 |
Topical treatment by urea reduces epidermal hyperproliferation and induces differentiation in psoriasis.
Topics: Administration, Topical; Adolescent; Cell Differentiation; Cell Division; Double-Blind Method; Epide | 1996 |
Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis.
Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; B-Lymphocytes; | 1998 |
A double-blind comparison of 0.1% dithranol in a 17% urea base ("Psoradrate") and base alone in the treatment of active chronic psoriasis.
Topics: Adolescent; Adult; Anthracenes; Anthralin; Child; Clinical Trials as Topic; Double-Blind Method; Dru | 1978 |
The action of a urea-lactic acid ointment in ichthyosis with particular reference to the thickness of the horny layer.
Topics: Adolescent; Adult; Aged; Female; Humans; Ichthyosis; Lactates; Male; Middle Aged; Ointment Bases; Ps | 1976 |
[Ambulatory external treatment of psoriasis vulgaris: comparison of the effectiveness of a dithranol and a glucocorticoid-containing preparation].
Topics: Administration, Topical; Adult; Anthralin; Clinical Trials as Topic; Desoximetasone; Dexamethasone; | 1988 |
Topical lomustine in the treatment of psoriasis.
Topics: Adult; Aged; Antineoplastic Agents; Blood Cell Count; Bone Marrow Diseases; Clinical Trials as Topic | 1972 |
Carbamide in hyperkeratosis.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Dermatitis, Atopic; Eval | 1973 |
Rapid weight reduction and psoriasis.
Topics: 17-Hydroxycorticosteroids; Adult; Aged; Aspartate Aminotransferases; Blood Urea Nitrogen; Body Weigh | 1971 |
40 other studies available for urea and Psoriasis
| Article | Year |
|---|---|
Assessment of the efficacy, skin acceptability and cosmetic quality of an adjuvant cream based on 40% urea and amino-inositol in the treatment of mild psoriasis.
Topics: Emollients; Humans; Psoriasis; Quality of Life; Treatment Outcome; Urea | 2022 |
Mode of action of urea.
Topics: Dermatitis, Atopic; Humans; Ichthyosis; Psoriasis; Skin; Urea | 2020 |
[Influence of an adjuvant treatment with an emollient containing 10 % urea, ceramides, glycerin und glyceryl glucoside in patients with psoriasis vulgaris].
Topics: Ceramides; Emollients; Glucosides; Glycerol; Humans; Psoriasis; Quality of Life; Severity of Illness | 2021 |
The metabolic analysis of psoriasis identifies the associated metabolites while providing computational models for the monitoring of the disease.
Topics: Adult; Aged; Alkanes; Amino Acids; Carnitine; Computer Simulation; Dicarboxylic Acids; Female; Human | 2017 |
Pityriasis rubra pilaris and severe hypereosinophilia.
Topics: Clobetasol; Dermatologic Agents; Diagnosis, Differential; Eosinophilia; Humans; Hydroxyzine; Isotret | 2017 |
Quantitative Analysis of Free Amino Acids and Urea Derived from Isolated Corneocytes of Healthy Young, Healthy Aged, and Diseased Skin.
Topics: Adolescent; Adult; Aged; Amino Acids; Dermatitis, Atopic; Female; Humans; Male; Middle Aged; Psorias | 2019 |
Ultrasound assessment of the keratolytic effect of a 50% urea anhydrous paste on psoriasis plaques: a prospective study.
Topics: Administration, Cutaneous; Adult; Aged; Female; Humans; Keratolytic Agents; Male; Middle Aged; Prosp | 2019 |
Drug Discovery against Psoriasis: Identification of a New Potent FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor, 1-(4-((1H-Pyrazolo[3,4-d]pyrimidin-4-yl)oxy)-3-fluorophenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea, That Showed Potent Activity in a Psoriatic Anim
Topics: Animals; Disease Models, Animal; Drug Discovery; fms-Like Tyrosine Kinase 3; Mice; Mice, Inbred BALB | 2016 |
Therapy of psoriasis in childhood and adolescence - a German expert consensus.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adrenal Cortex Hormones; Anthralin; Anti- | 2011 |
[Sulfonyl urea derivatives in treatment of psoriasis vulgaris; preliminary report].
Topics: Prednisolone; Psoriasis; Urea | 1958 |
[Therapeutic and clinical study on the efficacy of sulfonyl urea derivatives in psoriasis vulgaris].
Topics: Biomedical Research; Humans; Psoriasis; Urea | 1961 |
CRUDE COAL TAR IN DERMATOLOGIC THERAPY.
Topics: Blood Chemical Analysis; Coal Tar; Creatine; Creatinine; Dermatitis; Dermatitis, Atopic; Humans; Kid | 1964 |
Methotrexate: improving safety profile.
Topics: Blood Chemical Analysis; Collagen Type III; Dermatologic Agents; Drug Monitoring; Drug Utilization R | 2006 |
Psoriasiform eruption and pharyngitis.
Topics: Anti-Bacterial Agents; Foot; Hand; Humans; Injections, Intramuscular; Male; Ointments; Penicillin G | 2008 |
[Urea in psoriatic patients' blood (author's transl)].
Topics: Female; Humans; Male; Psoriasis; Urea | 1982 |
[Investigation of local therapy following urea pretreatment. First results (author's transl)].
Topics: Adolescent; Adult; Aged; Anthralin; Dexamethasone; Eczema; Female; Humans; Male; Middle Aged; Premed | 1981 |
[Dithranol-urea treatment of chronic psoriasis. A comparison of 0,1% dithranol + 17% urea with triamcinolone acetonite 0,1% and phototherapy (author's transl)].
Topics: Adolescent; Adult; Anthracenes; Anthralin; Drug Combinations; Female; Humans; Male; Middle Aged; Pho | 1981 |
A comparison of peritoneal transport in patients with psoriasis and uremia.
Topics: Adult; Aged; Blood Glucose; Blood Proteins; Calcium; Creatinine; Female; Humans; Male; Middle Aged; | 1981 |
Urea ointment in the nonsurgical avulsion of nail dystrophies--a reappraisal.
Topics: Dermatomycoses; Humans; Methods; Nail Diseases; Ointments; Pilot Projects; Psoriasis; Urea | 1980 |
[Potentiation of hydrocortisone by admixture of urea].
Topics: Administration, Topical; Anti-Inflammatory Agents; Drug Combinations; Eczema; Female; Humans; Hydroc | 1980 |
Results of a postmarketing drug monitoring survey with a polidocanol-urea preparation for dry, itching skin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child, Preschool; Dermatitis, Atopic; Drug Combinations; | 1997 |
Treatment of scalp seborrheic dermatitis and psoriasis with an ointment of 40% urea and 1% bifonazole.
Topics: Antifungal Agents; Dermatitis, Seborrheic; Humans; Imidazoles; Ointments; Psoriasis; Scalp Dermatose | 2000 |
Two tris urea mercaptoethanol extractable polypeptides found uniquely in scales of patients with psoriasis.
Topics: Humans; Immune Sera; Mercaptoethanol; Peptides; Psoriasis; Skin; Tromethamine; Urea | 1978 |
[Urea as a single drug in dry skin].
Topics: Administration, Topical; Dermatologic Agents; Drug Therapy, Combination; Eczema; Hand Dermatoses; Hu | 1989 |
[Water content of the skin following salicylic acid and urea treatment].
Topics: Administration, Topical; Adult; Body Water; Dermatologic Agents; Female; Hand Dermatoses; Humans; Ic | 1989 |
[Urea and urea combinations in psoriasis].
Topics: Administration, Topical; Anthralin; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Ther | 1989 |
[Studies of local treatment of psoriasis with a bifonazole-urea combination].
Topics: Administration, Topical; Dermatitis, Seborrheic; Drug Therapy, Combination; Female; Humans; Imidazol | 1987 |
[Clinical trial of a topical preparation containing urea, sunflower oil, evening primrose oil, wheat germ oil and sodium pyruvate, in several hyperkeratotic skin conditions].
Topics: Administration, Topical; Drug Combinations; Drug Evaluation; Fatty Acids, Essential; Fatty Acids, Un | 1986 |
[Short-term treatment of psoriasis vulgaris with dithranol with added urea].
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Child; Drug Combinations; Female; Humans; Male; Mid | 1985 |
A new treatment of ichthyosis and other hyperkeratotic conditions.
Topics: Adolescent; Adult; Aged; Eczema; Female; Humans; Humidity; Ichthyosis; Male; Ointments; Psoriasis; S | 1968 |
[An unknown metabolic disturbance of psoriasis vulgaris (author's transl)].
Topics: Adolescent; Adult; Dermatitis, Exfoliative; Dietary Proteins; Female; Humans; Hydroxyurea; Lymphocyt | 1974 |
Oligaemia, renal failure, and jaundice associated with acute pustular psoriasis.
Topics: Acute Disease; Acute Kidney Injury; Anuria; Blood Pressure; Blood Volume; Calcium; Capillary Permeab | 1974 |
[An unknowed keratolytic agent: urea].
Topics: Aspirin; Dermatologic Agents; Drug Combinations; Humans; Ichthyosis; Lanolin; Psoriasis; Urea | 1971 |
The abnormality of sweat duct function in psoriasis.
Topics: Absorption; Female; Humans; Lactates; Male; Pilocarpine; Potassium; Psoriasis; Sodium; Sweat; Sweat | 1969 |
[Effect of 6-azauridine-triacetate on the enzyme activity in psoriatic patients].
Topics: Arginase; Enzymes; Fructose-Bisphosphate Aldolase; Humans; L-Lactate Dehydrogenase; Malate Dehydroge | 1970 |
Effect of retinoic acid in psoriasis.
Topics: Aspartate Aminotransferases; Biopsy; Blood Cell Count; Carotenoids; Humans; Mitosis; Ointments; Psor | 1970 |
The quantitative analysis of some constituents of crude sweat.
Topics: Ammonia; Calcium; Chlorides; Chromium; Dermatitis, Atopic; Dermatitis, Contact; Humans; Hydrogen-Ion | 1970 |
[Free amino acids and other ninhydrin-positive substances in the normal horny layer and in psoriasis scales].
Topics: Alanine; Amino Acids; Ammonia; Asparagine; Chromatography; Citrulline; Cysteine; Glycine; Histidine; | 1967 |
Low-protein diet and psoriasis. A hospital study.
Topics: Adult; Aged; Blood Urea Nitrogen; Diet Therapy; Dietary Proteins; Female; Humans; Male; Middle Aged; | 1969 |
[On the diagnosis of latent psoriasis].
Topics: Adult; Child, Preschool; Cholesterol; Female; Humans; Male; Psoriasis; Urea | 1966 |